AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 11 filers reported holding AKARI THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3 | -40.0% | 16,437 | +56.7% | 0.00% | -100.0% |
| Q4 2022 | $5 | -100.0% | 10,491 | -37.1% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | -50.0% | 16,676 | -8.0% | 0.00% | -80.0% |
| Q2 2020 | $40,000 | -24.5% | 18,129 | -41.8% | 0.01% | +25.0% |
| Q3 2019 | $53,000 | +140.9% | 31,124 | +185.8% | 0.00% | +300.0% |
| Q2 2019 | $22,000 | -84.6% | 10,892 | -72.7% | 0.00% | -87.5% |
| Q1 2019 | $143,000 | +146.6% | 39,864 | +33.8% | 0.01% | +166.7% |
| Q2 2018 | $58,000 | – | 29,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 178,091 | $703,459 | 0.52% |